351 related articles for article (PubMed ID: 16636847)
21. Protein kinases as potential targets for novel anti-schistosomal strategies.
Beckmann S; Leutner S; Gouignard N; Dissous C; Grevelding CG
Curr Pharm Des; 2012; 18(24):3579-94. PubMed ID: 22607148
[TBL] [Abstract][Full Text] [Related]
22. Targeting schistosome histone modifying enzymes for drug development.
Pierce RJ; Dubois-Abdesselem F; Lancelot J; Andrade L; Oliveira G
Curr Pharm Des; 2012; 18(24):3567-78. PubMed ID: 22607147
[TBL] [Abstract][Full Text] [Related]
23. Re-positioning protein-kinase inhibitors against schistosomiasis.
Gelmedin V; Dissous C; Grevelding CG
Future Med Chem; 2015; 7(6):737-52. PubMed ID: 25996067
[TBL] [Abstract][Full Text] [Related]
24. Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.
El Kouni MH
Comp Biochem Physiol B Biochem Mol Biol; 2017 Nov; 213():55-80. PubMed ID: 28735972
[TBL] [Abstract][Full Text] [Related]
25. Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis.
Lee EF; Fairlie WD
Future Med Chem; 2015; 7(6):707-11. PubMed ID: 25996064
[No Abstract] [Full Text] [Related]
26. Current drug strategies for the treatment and control of schistosomiasis.
Villamizar-Monsalve MA; López-Abán J; Vicente B; Peláez R; Muro A
Expert Opin Pharmacother; 2024 Mar; 25(4):409-420. PubMed ID: 38511392
[TBL] [Abstract][Full Text] [Related]
27. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.
Doenhoff MJ; Hagan P; Cioli D; Southgate V; Pica-Mattoccia L; Botros S; Coles G; Tchuem Tchuenté LA; Mbaye A; Engels D
Parasitology; 2009 Nov; 136(13):1825-35. PubMed ID: 19281637
[TBL] [Abstract][Full Text] [Related]
28. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
Wang Y; Xu J; Xia C
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
[TBL] [Abstract][Full Text] [Related]
29. [Drug therapy of mansoni schistosomiasis].
Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
[TBL] [Abstract][Full Text] [Related]
30. Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.
Moreira-Filho JT; Silva AC; Dantas RF; Gomes BF; Souza Neto LR; Brandao-Neto J; Owens RJ; Furnham N; Neves BJ; Silva-Junior FP; Andrade CH
Front Immunol; 2021; 12():642383. PubMed ID: 34135888
[TBL] [Abstract][Full Text] [Related]
31. Macromolecular bases of antischistosomal therapy.
Angelucci F; Miele AE; Boumis G; Brunori M; Dimastrogiovanni D; Bellelli A
Curr Top Med Chem; 2011; 11(16):2012-28. PubMed ID: 21619508
[TBL] [Abstract][Full Text] [Related]
32. [Study progress on the mode of action of praziquantel against schistosomes].
Xiao SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of oltipraz versus praziquantel for treatment of schistosomiasis with intestinal manifestation in the Gabon (Schistosoma intercalatum and S. haematobium).
Kern P; Burchard GD; Dietrich M
Tropenmed Parasitol; 1984 Jun; 35(2):95-9. PubMed ID: 6464192
[TBL] [Abstract][Full Text] [Related]
34. Schistosomiasis chemotherapy.
Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
[TBL] [Abstract][Full Text] [Related]
35. Drug resistance to schistosomicides and other anthelmintics of medical significance.
Brindley PJ
Acta Trop; 1994 Mar; 56(2-3):213-31. PubMed ID: 8203304
[TBL] [Abstract][Full Text] [Related]
36. Better understanding of anti-schistosomal strategies through microarray analysis.
Gobert GN
Infect Disord Drug Targets; 2010 Aug; 10(4):251-7. PubMed ID: 20429867
[TBL] [Abstract][Full Text] [Related]
37. New 1,3-benzodioxole derivatives: Synthesis, evaluation of in vitro schistosomicidal activity and ultrastructural analysis.
Mariz Gomes da Silva LM; de Oliveira JF; Silva WL; da Silva AL; de Almeida Junior ASA; Barbosa Dos Santos VH; Alves LC; Brayner Dos Santos FA; Costa VMA; Aires AL; de Lima MDCA; Albuquerque MCPA
Chem Biol Interact; 2018 Mar; 283():20-29. PubMed ID: 29366735
[TBL] [Abstract][Full Text] [Related]
38. Schistosome transcriptomes: new insights into the parasite and schistosomiasis.
Hu W; Brindley PJ; McManus DP; Feng Z; Han ZG
Trends Mol Med; 2004 May; 10(5):217-25. PubMed ID: 15121048
[TBL] [Abstract][Full Text] [Related]
39. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Bergquist R; Utzinger J; Keiser J
Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
[TBL] [Abstract][Full Text] [Related]
40. Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?
Dissous C; Grevelding CG
Trends Parasitol; 2011 Feb; 27(2):59-66. PubMed ID: 20920890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
